APUS
#4891
Apimeds Pharmaceuticals US, Inc. Common Stock
3.8 8 USD
-0.01%
Market Price
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
Годовой диапазон
Дневное изменение
-0.51%
Месячное изменение
-29.07%
6-месячное изменение
+196.18%
Годовое изменение
+196.18%
Предыдущее закрытие
3.9 0
Open
3.9 0
Low
3.8 6
High
3.9 0
Volume
6
Financials
2026
Current report, 19 Aug 2026
Apimeds Pharmaceuticals US, Inc. current report, 19 August 2026
8-K
Current report, Q3 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Apimeds Pharmaceuticals US, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Apimeds Pharmaceuticals US, Inc. current report, Q1 FY2026
8-K